Popular Articles

Study Finds That Tobacco Companies Changed Design Of Cigarettes Without Alerting Smokers
As President Obama prepares to sign a bill giving the Food and Drug Administration (FDA) oversight of the tobacco industry, a new study from Harvard School of Public Health (HSPH) researchers shows that tobacco manufacturers have continually changed the ingredients and the design of their cigarettes over time, even if those changes have exceeded acceptable product variance guidelines. The result, say the researchers, is that consumers who buy the same brand of product are not made aware of how that product has been altered and what effect those alterations might have on their levels of addiction or harm.

Bill Would Allow Federal Funding For Needle Exchange Programs
House Democrats on Friday as part of a spending measure to fund the Departments of Labor and HHS for fiscal year 2010, "unveiled legislation to lift a ban on federal funding for needle-exchange programs, a shift to try to reduce [HIV infections] but one that will probably spark a fight," Reuters/Boston Globe reports (7/11). The ban has been included in the annual spending bill in previous years. House Appropriations Committee Chair David Obey (D-Wis.) said, "Scientific studies have documented that needle exchange programs, when implemented as part of a comprehensive prevention strategy, are an effective public health intervention for reducing [HIV] infections and do not promote drug use" (Reuters, Pelofsky, 7/10). "The move is in keeping with a pledge [President] Obama made during the primaries to remove the prohibition on such funding, although the ban was carried in his budget request this year," CQ Today reports (Wolfe, 7/10). However, "Republicans are girding for a fight over the ban and lawmakers could try to restore it as the legislation moves through the House during the next two weeks," according to Reuters (7/10). The bill also addresses sex education and "appears to continue Democrats" slow march away from funding abstinence-only sex education," CQ reports (7/10).
News of the day
Defeating Nicotine's Double Role In Lung Cancer
A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers.
Oncology

WHO Recommends Worldwide Use Of Rotavirus Vaccine For Children

To reduce an estimated half million deaths and two million hospitalizations from diarrhea caused by rotavirus each year, the WHO on Friday recommended that oral rotavirus vaccines be added to national childhood immunization programs, broadening access to the vaccine in the developing world, Reuters reports. Rotavirus - "a leading cause of severe gastroenteritis, including vomiting and diarrhea, in infants and young children" - "kills an estimated 1,600 children under the age of 5 every day, mostly in Africa and Asia," Reuters writes (MacInnis, Reuters, 6/5). GMANEWS.TV adds that 85 percent of rotavirus deaths are in Africa and Asia, "where patchy medical coverage means children with severe cases often don"t receive rehydration treatment in time to survive." Though the rotavirus vaccine has been a part of national immunization programs in Europe and the Americas for three years, until recently the vaccine had not been tested or approved for use in developing countries (GMANEWS.TV, 6/5). The WHO"s recommendation comes after recent clinical trials in South Africa and Malawi showed the oral vaccine reduced rotavirus-related diarrhea episodes in countries burdened by "high infant and child mortality, poor sanitary conditions, high diarrheal disease mortality and high maternal HIV prevalence," according to a release (WHO, 6/5). The guidance was issued prior to the completion of clinical trials in Bangladesh, Vietnam, Ghana, Mali and Kenya, "since available evidence indicates that efficacy data can be extrapolated to populations with similar mortality patterns regardless of geographic location," the WHO said (Reuters, 6/5). "This WHO recommendation clears the way for vaccines that will protect children in the developing world from one of the most deadly diseases they face," said Tachi Yamada, president of the Global Health Program at the Bill & Melinda Gates Foundation (WHO release, 6/5). However, because rotavirus is not the only cause of diarrhea, the WHO stressed efforts to "improve water quality, hygiene, and sanitation and ensure oral rehydration solutions and zinc supplements were available," BBC writes. While health experts worldwide lauded the WHO recommendation, the BBC also reported on UK scientists who have voiced concerns that the vaccine is too expensive, reports (BBC, 6/5). Fourteen nations in Africa and Asia are eligible for funding to buy vaccines through the Global Alliance for Vaccines and Immunization (GAVI) Alliance, which supports childhood immunization in developing countries, Bloomberg reports (Gale, Bloomberg, 6/5). According to Reuters, GAVI, the WHO and UNICEF "are now working to develop "a new accelerated and integrated approach" to tackle rotavirus diarrhea and pneumonia together. Those two vaccine-preventable diseases account for more than 35 percent of the world"s child deaths each year, the vast majority in poor countries, the WHO said" (Reuters, 6/5). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):